EVCNA Achieves First Impact Factor of 4.8
We are thrilled to share that Extracellular Vesicles and Circulating Nucleic Acids (EVCNA) has received its first Impact Factor of 4.8, as announced in the 2024 Journal Citation Reports (JCR) released by Clarivate Analytics on June 18, 2025.
According to the latest JCR rankings, EVCNA is positioned:
- 75th out of 319 journals (Q1) in Biochemistry & Molecular Biology
- 65th out of 204 journals (Q2) in Cell Biology
This outstanding achievement reflects the collective efforts and ongoing support of our Editorial Board members, guest editors, authors, reviewers, and readers worldwide. We sincerely thank you for your trust, dedication, and commitment to the journal.
Receiving our first Impact Factor marks the beginning of an exciting new chapter for EVCNA. We remain steadfast in our commitment to uphold scientific excellence, innovation, and integrity. We look forward to further advancing research in extracellular vesicle biology and nucleic acid-based diagnostics and therapeutics, in partnership with the global scientific community.
Let us move forward together in building EVCNA into a world-class open access journal that champions collaborative research, scientific innovation, and meaningful clinical translation.
Editor: Yan Lei
Language Editor: Catherine Yang
Production Editor: Ting Xu
Respectfully submitted by the Editorial Office of Extracellular Vesicles and Circulating Nucleic Acids
